High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial

Kristoffer S Hansen,Trine H Mogensen,Jane Agergaard,Berit Schiøttz-Christensen,Lars Østergaard,Line K Vibholm,Steffen Leth

The Lancet Regional Health - Europe（2023）

引用 12|浏览24

暂无评分

摘要

Placebo and CoQ10 capsules were provided by Pharma Nord, and the trial was supported by grants from the Novo Nordisk Foundation (NNF21OC0066984). This trial is registered with EudraCT, 2020-005961-16 and ClinicalTrials.gov, NCT04960215. The trial is completed.

查看译文

关键词

high-dose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要